Abbott Laboratories (ABT)
(Real Time Quote from BATS)
$113.58 USD
-1.23 (-1.07%)
Updated Sep 24, 2024 01:20 PM ET
4-Sell of 5 4
C Value D Growth B Momentum D VGM
Price, Consensus and EPS Surprise
ABT 113.58 -1.23(-1.07%)
Will ABT be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for ABT based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for ABT
Here's Why Abbott (ABT) Fell More Than Broader Market
Abbott Stock Hurt by Macroeconomic Issues & FX Headwind
ABT: What are Zacks experts saying now?
Zacks Private Portfolio Services
PAHC vs. ABT: Which Stock Is the Better Value Option?
Abbott (ABT) Rises Higher Than Market: Key Facts
High Tide Inc. (HITI) Surpasses Q3 Earnings and Revenue Estimates
Other News for ABT
Stocks that are expected to benefit from lower fed funds rate and a softer labor market
Abbott Declares 403rd Consecutive Quarterly Dividend
Abbott Laboratories declares $0.55 dividend
Abbott a new overweight at Piper Sandler; at attractive entry point
Five Below downgraded, DoorDash upgraded: Wall Street's top analyst calls